March 17, 2026- Roche announced an expansion of its global AI infrastructure, deploying a large-scale AI factory powered by a full stack of the latest-generation NVIDIA accelerated computing and AI. Featuring 2,176 high-performance GPUs on premises across the United States and Europe and embedded across the entire value chain, this infrastructure is designed to accelerate the development of diagnostics solutions and therapeutics. With this most recent investment, Roche’s combined on-premise and cloud GPU infrastructure now exceeds 3,500 Blackwell GPUs, which is the greatest announced GPU footprint available to a pharmaceutical company.
This computational expansion marks the next phase of a strategic NVIDIA collaboration that started in 2023. By leveraging NVIDIA AI infrastructure, Roche accelerates drug development through high-quality data and groundbreaking AI.